Editors' ChoiceCancer

A bullet against gallbladder cancer

See allHide authors and affiliations

Science Translational Medicine  18 Jul 2018:
Vol. 10, Issue 450, eaau7217
DOI: 10.1126/scitranslmed.aau7217


ERBB2/3 mutations in gallbladder cancer are associated with immunosuppression and aggressive tumor development and can be targeted by ERBB2/3 inhibitors.

View Full Text

Stay Connected to Science Translational Medicine